Clinical Trials Directory

Trials / Unknown

UnknownNCT04923737

Immunomodulatory Effects of Dexmedetomidine Infusion

Immunomodulatory Effects of Dexmedetomidine Infusion After Laparoscopic Major Abdominal Surgeries: Randomized Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Anesthetic management may affect both immunostimulatory and immunosuppressive mechanisms directly by modulating immune cell function or indirectly by attenuating the stress response, Thus, the choice of anesthetic technique may affect clinical outcomes by perturbing the balance between pro- and anti-inflammatory responses,anesthetics favoring this delicate balance are thus desirable as their use may reduce postoperative complications and mortality

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinepatients will receive a loading dose of IV Dexmedetomidine1μg/kg slowly just before induction of anesthesia, then Dexmedetomidine infusion started at a rate of 0.5μg/kg/h.
DRUG0.9% sodium chloridepatients will receive an equal volume of 0.9% sodium chloride (both the loading, and the infusion

Timeline

Start date
2022-01-01
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2021-06-11
Last updated
2022-06-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04923737. Inclusion in this directory is not an endorsement.